7th April 2026 — powered by CompoundingAI
Top Story
ICRA upgraded V-Guard Industries' long-term rating from [ICRA]AA to [ICRA]AA+ (Stable) on ₹820 Cr of rated facilities — driven by the complete repayment of the Sunflame acquisition loan. Gross debt fell from ₹291 Cr (March 2024) to ₹10.81 Cr (March 2025); net cash position is now +₹293.68 Cr. Interest coverage strengthened to 17.9x from 8.7x. In Q3 FY26, revenue grew 10.6% YoY to ₹1,404 Cr with EBITDA margin improving to 8.8%; management is targeting double-digit EBITDA margins by FY27 subject to copper price stability. (BSE filing, 7 Apr; VGUARD Q3 FY26 concall)
MIC Electronics is acquiring an 89.65% stake in Neo Semi SG Pte. Ltd. (Singapore) for ₹357.60 Cr — comprising ₹235.34 Cr via fresh equity shares issued at ₹41.38/share (vs CMP ₹34.48) and ₹122.26 Cr in cash. The acquisition is framed as a pivot toward semiconductor IP, AI-driven energy logistics, and IoT-based smart grids. The deal size equals 43% of MICEL's current market cap and approximately 5.7x its FY25 standalone revenue of ₹62.95 Cr, making this a transformative but high-execution-risk bet. Note: MICEL shareholders had pre-authorised investments up to ₹2,000 Cr under Section 186 of the Companies Act, and the company had flagged acquisition plans while raising authorized share capital earlier in FY25. (BSE filing, 7 Apr; MICEL FY25 Annual Report)
Prostarm won a ₹165 Cr EPC contract for a 50 MWac Solar PV Power Project in Maharashtra under MAHAGENCO, sub-contracted through Solarium Green Energy (which won a ₹188.52 Cr LOA from MAHAGENCO on April 1, 2026 as prime contractor). The order equals 21.5% of Prostarm's market cap — highly material for a company of this size. MAHAGENCO has additionally floated a 300 MW Phase-II EPC tender (bids due April 21, 2026), signalling continued pipeline for solar EPC players in Maharashtra. (BSE filing, 7 Apr; Solarium Green Energy press release, 1 Apr)
Refex secured a ₹70.2 Cr order for bulk industrial commodity supply from a Navratna PSU in the steel sector, with an execution timeline of approximately two months. The short execution cycle indicates a working capital-light, high-velocity business model. With ROE of 18.91% and ROCE of 20.89%, Refex has consistently demonstrated strong capital efficiency in its energy transition commodities business. (BSE filing, 7 Apr)
Camlin Fine Sciences is seeking shareholder approval to raise authorized share capital from ₹21.50 Cr to ₹25 Cr, enabling future fundraising via Rights Issue, QIP, or Preferential Allotment. The specialty chemicals company currently carries a negative ROE (-14.97%) and a PE of 839x on a near-breakeven basis — signalling that any equity raise would be dilutive for existing shareholders. (BSE filing, 7 Apr)
India Ratings affirmed Aditya Birla Capital's Long-Term Issuer Rating at IND AAA (Stable). Total rated amount increased 15.84% to ₹1.46L Cr from ₹1.26L Cr — reflecting meaningful business expansion while maintaining top-tier credit quality. In Q3 FY26, ABCL reported its highest-ever disbursements of ₹6,165 Cr (+30% YoY), AUM at ₹42,204 Cr (+58% YoY), and significantly improved asset quality with Stage 2+3 assets at 0.95% (-82 bps YoY). Management guides for NBFC loan book growth of 24-25% in FY27, consistent with doubling the book in three years. (BSE filing, 7 Apr; ABCAPITAL Q3 FY26 concall)
CARE reaffirmed Ahluwalia Contracts at CARE AA- (Stable), and notably increased the rated bank facility amount by 26% to ₹2,954 Cr from ₹2,345 Cr — an unusual expansion that signals lender confidence backing strong order growth. Ahluwalia's order book stood at ₹18,679 Cr as of December 2025 (2.5-3 years executable), against a target of ₹8,000 Cr fresh inflows this year — already exceeded at ₹9,562 Cr. FY26 revenue guidance was revised down to 10-15% (from 15-20%) due to NGT restrictions and project disruptions in Delhi, which accounts for 44% of the order book; management acknowledges its FY27 target of 15-20% is "slightly conservative." (BSE filing, 7 Apr; AHLUCONT Q3 FY26 concall)
Quess Corp appointed Mr. Lohit Bhatia as Whole-time Director and Group CEO, effective June 1, 2026, with a compensation package of ₹2 Cr fixed and ₹1.54 Cr variable annually. Simultaneously, the company introduced the Quess Stock Ownership Plan 2026 covering up to 52.5 lakh equity shares (3.52% of paid-up capital) — larger than its prior QSOP 2020 (36.5 lakh shares), signalling a step-up in leadership retention ambition. The CEO transition comes after Q3 FY26 saw EBITDA reach a new quarterly high of ₹80 Cr (+28% YoY) with margin expanding to 2.03% (+47 bps YoY); management is targeting 1 million associates over the next 4-5 years. (BSE filing, 7 Apr; QUESS Q3 FY26 concall)
Promoter group entity JBCG Advisory Services Private Limited acquired 3.00 crore equity shares of Centrum Capital for approximately ₹80.3 Cr at ₹26.77/share — comprising 2.72 Cr shares via warrant exercise and 27.69 lakh shares via open market. At 6.6% of market cap, this is a significant insider buying signal. Centrum separately approved fundraising of up to ₹1,000 Cr via NCDs in March 2026. Centrum Wealth manages ₹38,000+ Cr in client assets (30% YoY revenue growth in FY25); Unity Bank (associate entity) reported a net profit of ₹439 Cr with a Capital Adequacy Ratio of 36.4%. The promoter purchase may reflect conviction ahead of a potential capital raise cycle. (BSE filing, 7 Apr; CENTRUM FY25 Annual Report; CENTRUM March 2026 Announcement)
All three Independent Directors of Ikoma Technologies — Arvind Tiwari, Archana Chirawawala, and Sanjeev Seth — resigned simultaneously, citing "continuous non-compliance, lack of transparency, failure of management to respond, and ongoing legal exposure." In the same filing, the company appointed a new Executive Director, four new Independent Directors, a new Company Secretary, and a new CFO. Mass resignation of the full independent director board citing non-compliance and active legal exposure is a significant governance red flag. (BSE filing, 7 Apr)
CompoundingAI
Research workflows you can defend.
Every claim in this digest is sourced from company filings and verified data.
compoundingai.in
Disclaimer: This digest is for informational purposes only and should not be construed as investment advice. Nothing herein constitutes a recommendation to buy, sell, or hold any security. Past performance is not indicative of future results. Please consult a registered investment advisor before making investment decisions.
Powered by CompoundingAI — AI-powered Indian equity research